Table 2.
Five-year overall survival (%) for colorectal cancer patients according to stage, 2006–2015 (95% CI 1).
| Age Group | <75 Years Old | 75–79 Years Old | 80–84 Years Old | 85–89 Years Old | ≥90 Years Old |
|---|---|---|---|---|---|
| FCR 2 0 | 68.0 (65.8–70.2) | 43.9 (39.6–48.2) | 37.0 (33.3–40.7) | 18.3 (14.6–22.0) | 4.8 (2.1–7.5) |
| FCR 1 | 88.7 (87.5–89.9) | 72.7 (69.4–76.0) | 54.6 (50.5–58.7) | 38.5 (33.0–44.0) | 17.7 (9.7–25.7) |
| FCR 2 | 65.6 (63.4–67.8) | 52.2 (47.3–57.1) | 36.8 (31.7–41.9) | 32.3 (25.4–39.2) | 14.8 (4.4–25.2) |
| FCR 3 | 44.3 (42.5–46.1) | 36.7 (33.6–39.8) | 26.9 (23.8–30.0) | 17.2 (13.9–20.5) | 7.4 (3.3–11.5) |
| FCR 4 | 52.3 (48.4–56.2) | 39.1 (31.7–46.5) | 29.8 (22.7–36.9) | 19.8 (12.7–26.9) | 9.5 (2.1–16.9) |
| FCR 5 | 79.1 (77.1–81.1) | 60.4 (55.1–65.7) | 52.9 (47.2–58.6) | 42.8 (35.5–50.1) | 19.4 (9.4–29.4) |
| FCR 6 | 16.8 (14.6–19.0) | 4.1 (1.4–6.8) | 4.6 (1.5–7.7) | 0.8 (0.0–2.4) | 2.1 (0.0–6.2) |
| All patients | 61.7 (60.9–62.5) | 47.6 (46.0–49.2) | 36.6 (34.8–38.4) | 24.5 (22.5–26.5) | 9.0 (6.8–11.2) |
1 CI, confidence interval. 2 FCR, Finnish Cancer Registry classes: 0, unknown; 1, localized; 2, non-localized, regional lymph node metastasis only; 3, metastasized further than to regional lymph nodes or invading adjacent tissues; 4, non-localized, no information on extent; 5, locally advanced, tumor invasion to adjacent tissues; and 6, non-localized, including distant lymph node metastasis.